Recurrent candida prosthetic valve endocarditis following mitral valve replacement in hypertrophic obstructive cardiomyopathy

29 August 2026 (15:00 - 15:15)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Souna Boyadjian

Nork Marash Medical Center, Yerevan (Armenia)

3 More presentations in this session

Presentation thumbnail

Destructive prosthetic valve endocarditis after tavi complicated by cusp rupture and aorto–right atrial fistula

Miss D. Vasile (Bucharest, RO)

Presentation thumbnail

Long-term suppressive antimicrobial therapy guided by multimodality imaging in prosthetic mitral valve endocarditis due to Klebsiella pneumoniae in a non-surgical candidate

Doctor L. Di Vito (Ascoli Piceno, IT)

Presentation thumbnail

Unexpected Rhodotorula mucilaginosa co-infection revealed after surgery for destructive native aortic valve infective endocarditis with mitro-aortic pseudoaneurysm

Doctor I. Cristovao (Coimbra, PT)

Access the full session

Session thumbnail

Cases of prosthetic valve endocarditis: learning from experience

The Event

Event poster

ESC Congress 2026

29 August 2026 15:00 CET

You may be interested in

Congress Session

Personalised approach to decompensated heart failure

17 May 2025

Congress Presentation

Mitral regurgitation in obstructive hypertrophic cardiomyopathy: assessing the impact of mavacamten

13 December 2024

Congress Presentation

Catheter aspiration therapy for fungal pulmonary artery embolism following implantable-device endocarditis

25 March 2023

Congress Presentation

When mitral valve surgery makes the difference

13 December 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources